GB0325388D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0325388D0
GB0325388D0 GB0325388A GB0325388A GB0325388D0 GB 0325388 D0 GB0325388 D0 GB 0325388D0 GB 0325388 A GB0325388 A GB 0325388A GB 0325388 A GB0325388 A GB 0325388A GB 0325388 D0 GB0325388 D0 GB 0325388D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0325388A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0325388A priority Critical patent/GB0325388D0/en
Publication of GB0325388D0 publication Critical patent/GB0325388D0/en
Priority to PE2004000610A priority patent/PE20050285A1/en
Priority to ARP040102163A priority patent/AR044852A1/en
Priority to DK04740213T priority patent/DK1648934T3/en
Priority to MYPI20042450A priority patent/MY145375A/en
Priority to EP04740213A priority patent/EP1648934B1/en
Priority to TW093118140A priority patent/TWI361194B/en
Priority to PCT/EP2004/006794 priority patent/WO2005000893A2/en
Priority to ES04740213T priority patent/ES2328144T3/en
Priority to BRPI0411820A priority patent/BRPI0411820B8/en
Priority to NZ544157A priority patent/NZ544157A/en
Priority to SI200431269T priority patent/SI1648934T1/en
Priority to MXPA05013821A priority patent/MXPA05013821A/en
Priority to US10/560,751 priority patent/US20070093412A1/en
Priority to PT04740213T priority patent/PT1648934E/en
Priority to CL200401579A priority patent/CL2004001579A1/en
Priority to AU2004251866A priority patent/AU2004251866B2/en
Priority to PL04740213T priority patent/PL1648934T3/en
Priority to KR1020057024845A priority patent/KR101124136B1/en
Priority to RU2006101720/15A priority patent/RU2355418C2/en
Priority to DE602004022420T priority patent/DE602004022420D1/en
Priority to JP2006516037A priority patent/JP4746541B2/en
Priority to CA2529449A priority patent/CA2529449C/en
Priority to AT04740213T priority patent/ATE438659T1/en
Priority to CN200480017884.6A priority patent/CN1812997B/en
Priority to IL172329A priority patent/IL172329A/en
Priority to EC2005006237A priority patent/ECSP056237A/en
Priority to MA28680A priority patent/MA27862A1/en
Priority to CO05130258A priority patent/CO5650225A2/en
Priority to IS8247A priority patent/IS2705B/en
Priority to NO20060375A priority patent/NO330706B1/en
Priority to HK06110030.5A priority patent/HK1089776A1/en
Priority to US12/359,527 priority patent/US8299209B2/en
Priority to CY20091101022T priority patent/CY1109444T1/en
Priority to HR20090571T priority patent/HRP20090571T1/en
Priority to US13/628,900 priority patent/US20130035286A1/en
Ceased legal-status Critical Current

Links

GB0325388A 2003-06-24 2003-10-30 Organic compounds Ceased GB0325388D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GB0325388A GB0325388D0 (en) 2003-10-30 2003-10-30 Organic compounds
PE2004000610A PE20050285A1 (en) 2003-06-24 2004-06-22 PHARMACEUTICAL COMPOSITION INCLUDING CYCLIC ANALOGS OF SOMATOSTATIN
ARP040102163A AR044852A1 (en) 2003-06-24 2004-06-22 A PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION THAT INCLUDES A SOMATOSTATINE ANALOG
CN200480017884.6A CN1812997B (en) 2003-06-24 2004-06-23 Pharmaceutical composition outside stomach intestine containing somatostatin analogue
AU2004251866A AU2004251866B2 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
DE602004022420T DE602004022420D1 (en) 2003-06-24 2004-06-23 PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLIC SOMATOSTATIN ANALOGUE
EP04740213A EP1648934B1 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
TW093118140A TWI361194B (en) 2003-06-24 2004-06-23 Pharmaceutical composition for parenteral administration comprising somatostatin analogue and the use thereof
PCT/EP2004/006794 WO2005000893A2 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostin analogues
ES04740213T ES2328144T3 (en) 2003-06-24 2004-06-23 PHARMACACEUTICAL COMPOSITION THAT INCLUDES SOMATOSTATINE CYCLING ANALOGS
BRPI0411820A BRPI0411820B8 (en) 2003-06-24 2004-06-23 pharmaceutical composition for parenteral administration, and its uses
NZ544157A NZ544157A (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
SI200431269T SI1648934T1 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
MXPA05013821A MXPA05013821A (en) 2003-06-24 2004-06-23 Pharmaceutical composition.
US10/560,751 US20070093412A1 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
PT04740213T PT1648934E (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
CL200401579A CL2004001579A1 (en) 2003-06-24 2004-06-23 PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ANALOG OF SOMATOSTATIN AND TARTARIC ACID, WHERE THE COMPOSITION HAS THE REGULATED PH BETWEEN 4 AND 4.5 AND THE ACTIVE COMPOUND IS L CYCLE [{4- (NH2-C2H4-NH-CP-O) PRO} - PHG-DTRP-LYS-TYR (4-BZL) -PHE]; AND ITS USE FOR PREPA
DK04740213T DK1648934T3 (en) 2003-06-24 2004-06-23 Pharmaceutical composition containing cyclic somatostatin analogues
PL04740213T PL1648934T3 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
KR1020057024845A KR101124136B1 (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
RU2006101720/15A RU2355418C2 (en) 2003-06-24 2004-06-23 Pharmaceutical composition
MYPI20042450A MY145375A (en) 2003-06-24 2004-06-23 Pharmaceutical composition
JP2006516037A JP4746541B2 (en) 2003-06-24 2004-06-23 Pharmaceutical composition containing cyclic somatostatin analog
CA2529449A CA2529449C (en) 2003-06-24 2004-06-23 Pharmaceutical composition comprising cyclic somatostatin analogues
AT04740213T ATE438659T1 (en) 2003-06-24 2004-06-23 PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLIC SOMATOSTATIN ANALOGS
IL172329A IL172329A (en) 2003-06-24 2005-12-01 Pharmaceutical composition comprising cyclic somatostatin analogues and use thereof for the preparation of a medicament for acromegaly or cancer
EC2005006237A ECSP056237A (en) 2003-06-24 2005-12-19 PHARMACEUTICAL COMPOSITION THAT INCLUDES CYCLIC SOMATOSTATIN ANALOGS
MA28680A MA27862A1 (en) 2003-06-24 2005-12-21 PHARMACEUTICAL COMPOSITION
CO05130258A CO5650225A2 (en) 2003-06-24 2005-12-27 PHARMACEUTICAL COMPOSITION THAT INCLUDES ANALOGS OF SOMATOSTATINA CICLICOS
IS8247A IS2705B (en) 2003-06-24 2006-01-20 A pharmaceutical composition comprising cyclic growth hormone stimulating analogues
NO20060375A NO330706B1 (en) 2003-06-24 2006-01-24 Pharmaceutical composition comprising somatostatin analogue and tartaric acid and their use
HK06110030.5A HK1089776A1 (en) 2003-06-24 2006-09-08 Pharmaceutical composition comprising cyclic somatostatin analogues
US12/359,527 US8299209B2 (en) 2003-06-24 2009-01-26 Pharmaceutical composition comprising cyclic somatostatin analogues
CY20091101022T CY1109444T1 (en) 2003-06-24 2009-09-30 PHARMACEUTICAL COMPOSITION CONTAINING CYCLICAL SOMATOSTATIN analogues
HR20090571T HRP20090571T1 (en) 2003-06-24 2009-10-27 Pharmaceutical composition comprising cyclic somatostatin analogues
US13/628,900 US20130035286A1 (en) 2003-06-24 2012-09-27 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0325388A GB0325388D0 (en) 2003-10-30 2003-10-30 Organic compounds

Publications (1)

Publication Number Publication Date
GB0325388D0 true GB0325388D0 (en) 2003-12-03

Family

ID=29725672

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0325388A Ceased GB0325388D0 (en) 2003-06-24 2003-10-30 Organic compounds

Country Status (1)

Country Link
GB (1) GB0325388D0 (en)

Similar Documents

Publication Publication Date Title
GB0301259D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
GB0306715D0 (en) Organic compounds
GB0307553D0 (en) Organic compounds
GB0307856D0 (en) Organic compounds
GB0302876D0 (en) Organic compounds
GB0307860D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0301471D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0303506D0 (en) Organic compounds
GB0307277D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
GB0307440D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0303321D0 (en) Organic compounds
GB0301262D0 (en) Organic compounds
GB0302750D0 (en) Organic compounds
GB0302874D0 (en) Organic compounds
GB0302745D0 (en) Organic compounds
GB0302433D0 (en) Organic compounds
GB0303095D0 (en) Organic compounds
GB0325388D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)